G35.B2
Non-active primary progressive multiple sclerosis
Clinical Classification Guidelines
Inclusion Terms
- Primary progressive multiple sclerosis without evidence of inflammatory disease activity
Medical Intelligence & Overview
Non-active primary progressive multiple sclerosis (PPMS) is a form of multiple sclerosis characterized by a gradual worsening of neurological functions from the onset, without any periods of remission or relapses. Unlike other types of MS, where flare-ups are common, in this form, symptoms tend to progress steadily over time. It is classified under ICD-10 code G35.B2, distinguishing it from other MS subtypes due to its unique progression pattern and lack of observable inflammatory activity.
Causes & Symptoms
Clinical Causes: T h e p r e c i s e c a u s e o f p r i m a r y p r o g r e s s i v e m u l t i p l e s c l e r o s i s r e m a i n s u n k n o w n . I t i s b e l i e v e d t o r e s u l t f r o m a c o m b i n a t i o n o f g e n e t i c a n d e n v i r o n m e n t a l f a c t o r s t h a t t r i g g e r i m m u n e s y s t e m a b n o r m a l i t i e s , l e a d i n g t o n e r v e d a m a g e . I n n o n - a c t i v e P P M S , t h i s n e r v e d a m a g e o c c u r s w i t h o u t o n g o i n g i n f l a m m a t i o n , s u g g e s t i n g t h a t n e u r o d e g e n e r a t i o n m i g h t b e d r i v e n b y m e c h a n i s m s o t h e r t h a n a c t i v e i n f l a m m a t i o n .
Key Symptoms: Gradual increase in muscle weakness Trouble with coordination and balance Chronic fatigue Persistent numbness or tingling sensations Bladder and bowel dysfunction Difficulty walking or gait disturbances Gradual decline in cognitive functions in some cases Spasticity or muscle stiffness
Diagnostic & Treatment
Diagnosis Path: Diagnosing non-active primary progressive MS involves multiple steps, including: - Comprehensive neurological examination to assess motor and sensory functions, - Magnetic Resonance Imaging (MRI) scans that reveal characteristic brain and spinal cord changes, - Exclusion of other potential causes for neurological decline, - Evidence of disease progression over time without active inflammation, - Laboratory tests such as cerebrospinal fluid analysis, although these are less definitive in non-active cases. The absence of active inflammation distinguishes this MS subtype from others, requiring careful monitoring over extended periods to confirm the steady progression characteristic of PPMS.
Treatment Protocols: While there is no cure for non-active primary progressive MS, treatment strategies focus on managing symptoms and maintaining quality of life. Common approaches include: - Physical therapy to improve mobility and reduce spasticity, - Medications to manage muscle stiffness, pain, and fatigue, - Assistive devices for mobility support, - Psychosocial support to address emotional and cognitive challenges, - Vigilant monitoring for any signs of disease activity or progression, - Emerging therapies and clinical trials targeting neurodegeneration, which may offer future options. Healthcare providers tailor treatment plans to individual needs, emphasizing symptom control and daily functioning.
Clinical Advice & FAQs
Billing Guidance
Is G35.B2 a billable ICD-10 code?
Yes, G35.B2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G35.B2?
Clinical documentation must specify the nature of Non-active primary progressive multiple sclerosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference